BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 23020854)

  • 1. Molecular roadblocks for cellular reprogramming.
    Vierbuchen T; Wernig M
    Mol Cell; 2012 Sep; 47(6):827-38. PubMed ID: 23020854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
    Sadahiro T; Yamanaka S; Ieda M
    Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct reprogramming of mouse fibroblasts into cardiac myocytes.
    Inagawa K; Ieda M
    J Cardiovasc Transl Res; 2013 Feb; 6(1):37-45. PubMed ID: 23054660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration.
    He WJ; Hou Q; Han QW; Han WD; Fu XB
    Tissue Eng Part B Rev; 2014 Aug; 20(4):304-13. PubMed ID: 24063625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From fibroblast cells to cardiomyocytes: direct lineage reprogramming.
    Yang L
    Stem Cell Res Ther; 2011 Jan; 2(1):1. PubMed ID: 21241459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Cellular Reprogramming: The Next Generation.
    Srivastava D; DeWitt N
    Cell; 2016 Sep; 166(6):1386-1396. PubMed ID: 27610565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reprogramming of somatic cells. Problems and solutions].
    Schneider TA; Fishman VS; Liskovykh MA; Ponamartsev SV; Serov OL; Tomilin AN; Alenina N
    Tsitologiia; 2014; 56(12):869-80. PubMed ID: 25929128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate Reprogramming of Mouse Skin Fibroblasts into Stem-Like Cells by Bone Morphogenetic Protein 4.
    Lee SE; Uhm SJ; Son YJ; Park YG; Kim EY; Park SP
    Cell Reprogram; 2017 Apr; 19(2):107-115. PubMed ID: 28170287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Future of Direct Cardiac Reprogramming: Any
    López-Muneta L; Miranda-Arrubla J; Carvajal-Vergara X
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
    Ebrahimi B
    Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells.
    Biswas D; Jiang P
    Int J Mol Sci; 2016 Feb; 17(2):226. PubMed ID: 26861316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
    Xie M; Tang S; Li K; Ding S
    Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxO3a contributes to the reprogramming process and the differentiation of induced pluripotent stem cells.
    Wang Y; Tian C; Zheng JC
    Stem Cells Dev; 2013 Nov; 22(22):2954-63. PubMed ID: 23815557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate Standstill Clones Trapped in the Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.
    Zhang L; Wang Y; Zhang Y; Wang L; Huang H
    Cell Reprogram; 2020 Apr; 22(2):99-105. PubMed ID: 32182120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo reprogramming for tissue regeneration and organismal rejuvenation.
    Taguchi J; Yamada Y
    Curr Opin Genet Dev; 2017 Oct; 46():132-140. PubMed ID: 28779646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A blueprint for engineering cell fate: current technologies to reprogram cell identity.
    Morris SA; Daley GQ
    Cell Res; 2013 Jan; 23(1):33-48. PubMed ID: 23277278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.
    Horisawa K; Suzuki A
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(4):131-158. PubMed ID: 32281550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Promise of Cardiac Regeneration by In Situ Lineage Conversion.
    Nam YJ; Munshi NV
    Circulation; 2017 Mar; 135(10):914-916. PubMed ID: 28264888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.